TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12459665

Group type: EXPERIMENTAL
Intervention: IDD-D Propofol (2.5 mg/kg bolus + 0.2 mg/kg/min infusion for 30 min)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: IDD-D Propofol (30-min infusion)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Diprivan
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: IDD-D Propofol
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 24
Study: 10362414

Group type: EXPERIMENTAL
Intervention: Humid‐Vent Filter Light HMEF
Number of subjects: 140

Group type: COMPARATOR
Intervention: Clear ThermAl HMEF
Number of subjects: 140
Study: 7589025

Group type: EXPERIMENTAL
Intervention: Fatty cream 0.1% mometasone furoate (EFC)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Fatty cream 0.1% hydrocortisone‐17‐butyrate (LLFC)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 12
Study: 2248115

Group type: EXPERIMENTAL
Intervention: Self-regulation training (three groups with different intensities)
Number of subjects: 40
Study: 7004827

Group type: EXPERIMENTAL
Intervention: Fenclofenac (900 mg daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Indometacin (100 mg daily)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fenclofenac
Number of subjects: 30

Group type: COMPARATOR
Intervention: Indometacin
Number of subjects: 30
Study: 31287129

Group type: EXPERIMENTAL
Intervention: Use of muscle relaxant
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Sniffing position
Number of subjects: 132

Group type: COMPARATOR
Intervention: No muscle relaxant
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group (no muscle relaxant)
Number of subjects: 132
Study: 28634002

Group type: EXPERIMENTAL
Intervention: Standard treatment + acupressure (AP group)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard treatment (ST group)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard treatment + mock acupressure (mock AP group)
Number of subjects: 62
Study: 26721913

Group type: EXPERIMENTAL
Intervention: Health literacy
Number of subjects: 575

Group type: COMPARATOR
Intervention: Age (≥ 65 years)
Number of subjects: 575
Study: 24147918

Group type: EXPERIMENTAL
Intervention: Meal provision
Number of subjects: 112

Group type: COMPARATOR
Intervention: Self‐directed diet
Number of subjects: 112
Study: 22137462

Group type: EXPERIMENTAL
Intervention: Rimonabant (20mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20662907

Group type: EXPERIMENTAL
Intervention: Initial periodontal treatment
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control group (no initial periodontal treatment)
Number of subjects: 136
Study: 17562236

Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI)
Number of subjects: 0
Study: 16004813

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy combined with surgery (36 patients)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Surgery alone (32 patients)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy combined with surgery
Number of subjects: 68
Study: 10677808

Group type: EXPERIMENTAL
Intervention: Hydrocolloid patches containing TACA (triamcinolone acetonide)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydrocolloid patches containing TACA
Number of subjects: 0
Study: 9289305

Group type: EXPERIMENTAL
Intervention: Allergovit
Number of subjects: 699

Group type: COMPARATOR
Intervention: Catalet
Number of subjects: 699
Study: 8422849

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Nondrug conditions
Number of subjects: 15
Study: 3790382

Group type: EXPERIMENTAL
Intervention: DDD 100
Number of subjects: 10

Group type: COMPARATOR
Intervention: VVI
Number of subjects: 10

Group type: COMPARATOR
Intervention: DDD 150
Number of subjects: 10
Study: 30527790

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT)
Number of subjects: 71
Study: 28707567

Group type: EXPERIMENTAL
Intervention: Powerful Together with Diabetes intervention group
Number of subjects: 131

Group type: COMPARATOR
Intervention: Standard diabetes education (control group)
Number of subjects: 131
Study: 25231130

Group type: EXPERIMENTAL
Intervention: Gleason score (GS) categories <3 + 3, 3 + 4, 4 + 3, >4 + 4
Number of subjects: 3282

Group type: EXPERIMENTAL
Intervention: Higher Gleason scores
Number of subjects: 3282

Group type: COMPARATOR
Intervention: Biopsy GS from England
Number of subjects: 3282

Group type: EXPERIMENTAL
Intervention: Gleason score drift
Number of subjects: 3282
Study: 22983593

Group type: EXPERIMENTAL
Intervention: Atropine 10 μg/kg
Number of subjects: 46

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 46
Study: 21429067

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 vaginal gel (1 mg/2 mg)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Prostaglandin E2 vaginal tablets (3 mg)
Number of subjects: 165
Study: 19233432

Group type: EXPERIMENTAL
Intervention: Naftopidil 50 mg daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Watchful waiting (Control)
Number of subjects: 60
Study: 16944044

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) replacement therapy for 24 months
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no GH replacement)
Number of subjects: 10
Study: 12738139

Group type: EXPERIMENTAL
Intervention: Metronidazole (250 mg orally three times per day) and erythromycin (250 mg orally four times per day) for 10 days
Number of subjects: 715

Group type: COMPARATOR
Intervention: Placebo pills for 10 days
Number of subjects: 715
Study: 11033399

Group type: EXPERIMENTAL
Intervention: Silicone IOL
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Acrylic IOL
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: PMMA IOL
Number of subjects: 240
Study: 9071898

Group type: EXPERIMENTAL
Intervention: Multimodal therapy (pre‐operative chemotherapy, Patey mastectomy, flap irradiation and adjuvant hormone therapy)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Initial hormone therapy
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Multimodal therapy
Number of subjects: 108

Group type: COMPARATOR
Intervention: Hormone therapy
Number of subjects: 108
Study: 8416161

Group type: EXPERIMENTAL
Intervention: Tolrestat (200 mg/d given in the morning)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 3518400

Group type: EXPERIMENTAL
Intervention: Hemalet
Number of subjects: 31

Group type: COMPARATOR
Intervention: Simplate II
Number of subjects: 31
Study: 29764671

Group type: EXPERIMENTAL
Intervention: Subclinical atrial fibrillation (SCAF)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Subclinical atrial fibrillation (SCAF) detected within 30 days before stroke
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Patients with SCAF
Number of subjects: 44

Group type: COMPARATOR
Intervention: Patients without SCAF
Number of subjects: 44
Study: 27992261

Group type: EXPERIMENTAL
Intervention: Testosterone gel for 14 weeks (TAP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Testosterone gel for 36 months (TEAAM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (TAP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (TEAAM)
Number of subjects: 0
Study: 25615959

Group type: EXPERIMENTAL
Intervention: Higher IL-6 levels
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Higher tumor necrosis factor-α levels
Number of subjects: 62
Study: 24246619

Group type: EXPERIMENTAL
Intervention: Intraoperative air leak test (ALT)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Non-ALT
Number of subjects: 103
Study: 21135170

Group type: EXPERIMENTAL
Intervention: Oral glucocorticosteroids (GCSs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GCS-pretreated LCs
Number of subjects: 0

Group type: COMPARATOR
Intervention: TGF-β blockage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combination of anti-TGF-β and anti-IL-10 Abs
Number of subjects: 0
Study: 18973494

Group type: EXPERIMENTAL
Intervention: Early losartan therapy
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control (no losartan therapy)
Number of subjects: 97
Study: 17165637

Group type: EXPERIMENTAL
Intervention: ezetimibe/simvastatin, 10/20 mg/d
Number of subjects: 1229

Group type: EXPERIMENTAL
Intervention: ezetimibe/simvastatin, 10/40 mg/d
Number of subjects: 1229

Group type: EXPERIMENTAL
Intervention: ezetimibe/simvastatin
Number of subjects: 1229

Group type: COMPARATOR
Intervention: atorvastatin
Number of subjects: 1229
Study: 12670129

Group type: EXPERIMENTAL
Intervention: Pentagastrin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ethinyl estradiol (EE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10636613

Group type: EXPERIMENTAL
Intervention: Moderate hyperventilation
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cerebrovenous blood temperature monitoring during CPP reduction
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cerebrovenous blood temperature before hyperventilation
Number of subjects: 24
Study: 7761882

Group type: EXPERIMENTAL
Intervention: loratadine 10mg daily
Number of subjects: 39

Group type: COMPARATOR
Intervention: astemizole 10mg daily
Number of subjects: 39
Study: 3287943

Group type: EXPERIMENTAL
Intervention: SCH 33861 (topical angiotensin converting enzyme inhibitor)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Timolol 0.5%
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 28688960

Group type: EXPERIMENTAL
Intervention: Massage combined with phototherapy
Number of subjects: 134

Group type: COMPARATOR
Intervention: Phototherapy only
Number of subjects: 134
Study: 26041587

Group type: EXPERIMENTAL
Intervention: Fibrin Pad (FP)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Fibrin Pad (FP) and Standard of Care (SoC)
Number of subjects: 91
Study: 23603517

Group type: EXPERIMENTAL
Intervention: Repeated-slip training before encountering a novel, unannounced trip while walking
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Mixed training with both types of perturbation (trips and slips)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (only experienced the novel, unannounced trip)
Number of subjects: 32
Study: 21454959

Group type: COMPARATOR
Intervention: nCPAP
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: MAD
Number of subjects: 43
Study: 19738134

Group type: EXPERIMENTAL
Intervention: Accelerated infusion of streptokinase
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional infusion of streptokinase
Number of subjects: 120
Study: 17692719

Group type: EXPERIMENTAL
Intervention: Varenicline 1 mg BID
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 15172407

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 5010

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5010
Study: 11876933

Group type: EXPERIMENTAL
Intervention: CD3AK cells cultured in serum-free medium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 0
Study: 9730797

Group type: EXPERIMENTAL
Intervention: Cytokine measurement (IL-6, TNF-alpha, IFN-gamma) in patients with pneumonia
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Cytokine measurement (IL-6, TNF-alpha, IFN-gamma) in patients with Chlamydia pneumonia
Number of subjects: 44
Study: 7756208

Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 794

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 794

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 794

Group type: EXPERIMENTAL
Intervention: Migraine
Number of subjects: 794

Group type: EXPERIMENTAL
Intervention: Previous non-cerebral thrombotic disease
Number of subjects: 794

Group type: EXPERIMENTAL
Intervention: Other predisposing medical diseases
Number of subjects: 794
Study: 2264427

Group type: EXPERIMENTAL
Intervention: Excision and primary closure
Number of subjects: 96

Group type: COMPARATOR
Intervention: Excision and healing by secondary granulation
Number of subjects: 96
Study: 431635

Group type: EXPERIMENTAL
Intervention: Children less than 24 months of age
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: White children
Number of subjects: 107
Study: 31423922

Group type: EXPERIMENTAL
Intervention: Anticoagulation initiated on Day 3
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Anticoagulation initiated on Day 6
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Anticoagulation initiated on Day 10
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Anticoagulation initiated on Day 14
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Anticoagulation initiated on Day 6 (for severe stroke)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Anticoagulation initiated on Day 10 (for severe stroke)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Anticoagulation initiated on Day 14 (for severe stroke)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Anticoagulation initiated on Day 21 (for severe stroke)
Number of subjects: 1500
Study: 28284883

Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 128

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 128
Study: 25869025

Group type: EXPERIMENTAL
Intervention: I:E ratio of 1:1
Number of subjects: 80

Group type: COMPARATOR
Intervention: I:E ratio of 1:2
Number of subjects: 80
Study: 23316063

Group type: COMPARATOR
Intervention: Ringer (control)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 10 mM N(G)-nitro-l-arginine methyl ester (l-NAME; NO synthase inhibitor)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 10 mM ketorolac (COX inhibitor)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination of l-NAME + ketorolac
Number of subjects: 24
Study: 21077801

Group type: EXPERIMENTAL
Intervention: Low-dose prednisolone (5-7.5 mg) for at least 2 years (P-group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No prednisolone treatment (NoP-group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Prednisolone treatment
Number of subjects: 100
Study: 19808874

Group type: EXPERIMENTAL
Intervention: Ipilimumab at 3 mg/kg and then monthly at 1 mg/kg x 3 months (dose level 1), escalating to 3 mg/kg monthly x 4 months (dose level 2)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ipilimumab
Number of subjects: 18
Study: 16739319

Group type: EXPERIMENTAL
Intervention: Intraarterial ACNU administration (17 patients)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Intravenous ACNU administration (16 patients)
Number of subjects: 33
Study: 14715359

Group type: EXPERIMENTAL
Intervention: Nesiritide
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-dose nitroglycerin
Number of subjects: 0
Study: 11333081

Group type: EXPERIMENTAL
Intervention: Ingroup
Number of subjects: 258

Group type: COMPARATOR
Intervention: Outgroup
Number of subjects: 258
Study: 9140895

Group type: EXPERIMENTAL
Intervention: URI group (inoculated with HRV 16)
Number of subjects: 55

Group type: COMPARATOR
Intervention: CRL group (non-infected control)
Number of subjects: 55
Study: 7798535

Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate 500 micrograms twice a day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3277875

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 vaginal suppositories (2.5 mg PGE2 in Witepsol S55)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Intracervical prostaglandin gel (1 mg PGE2 in 5 g hydroxypropylmethyl cellulose)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 vaginal suppositories
Number of subjects: 113

Group type: COMPARATOR
Intervention: Intracervical prostaglandin gel
Number of subjects: 113
Study: 30947574

Group type: EXPERIMENTAL
Intervention: Three-port laparoscopic right hemicolectomy (TPLRC)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Five-port laparoscopic right hemicolectomy (FPLRC)
Number of subjects: 168
Study: 29678471

Group type: EXPERIMENTAL
Intervention: Radium-223 (Ra-223) therapy
Number of subjects: 571

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 571
Study: 28774396

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 2305

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 2305
Study: 26223227

Group type: EXPERIMENTAL
Intervention: Negative pressure wound device
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard adhesive gauze dressing
Number of subjects: 300
Study: 23837838

Group type: EXPERIMENTAL
Intervention: Lower tidal volumes
Number of subjects: 150

Group type: COMPARATOR
Intervention: Conventional tidal volumes
Number of subjects: 150
Study: 20160637

Group type: EXPERIMENTAL
Intervention: Laparoscopic-assisted distal gastrectomy (LADG)
Number of subjects: 342

Group type: COMPARATOR
Intervention: Open gastrectomy (ODG)
Number of subjects: 342
Study: 19055226

Group type: EXPERIMENTAL
Intervention: SLS (dentifrice with SLS)
Number of subjects: 25
Study: 16870282

Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 126
Study: 12808010

Group type: EXPERIMENTAL
Intervention: Behavioral interventions focusing on social support, knowledge, and self-efficacy
Number of subjects: 354
Study: 11014375

Group type: EXPERIMENTAL
Intervention: Vasodilator therapy in chronic aortic regurgitation (AR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vasodilator therapy in chronic mitral regurgitation (MR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vasodilator therapy in mitral valve prolapse or hypertrophic cardiomyopathy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vasodilator therapy in other primary causes of MR
Number of subjects: 0
Study: 8617901

Group type: EXPERIMENTAL
Intervention: Salt-sensitive hypertensive patients
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Salt-sensitive hypertensive patients < 44 years
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Salt-sensitive hypertensive patients 44 to 64 years
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Salt-sensitive hypertensive patients > or = 65 years
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Salt-sensitive hypertensive patients of all ages
Number of subjects: 65

Group type: COMPARATOR
Intervention: Normotensive controls
Number of subjects: 65
Study: 1359210

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Mini cholecystectomy (MC)
Number of subjects: 70
Study: 6545088

Group type: EXPERIMENTAL
Intervention: Valium Roche mixed Micelles
Number of subjects: 119

Group type: COMPARATOR
Intervention: Diazemuls
Number of subjects: 119
Study: 30702758

Group type: EXPERIMENTAL
Intervention: Culturally adapted guided internet‐based cognitive behavior therapy (ICBT) for 8 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 50
Study: 30446003

Group type: EXPERIMENTAL
Intervention: Screening trial prior to SCS implant
Number of subjects: 100

Group type: COMPARATOR
Intervention: Implantation-only strategy
Number of subjects: 100
Study: 26415549

Group type: EXPERIMENTAL
Intervention: Temoporfin photodynamic therapy (PDT) plus chemotherapy and stent
Number of subjects: 20

Group type: COMPARATOR
Intervention: Chemotherapy and stent without temoporfin PDT
Number of subjects: 20
Study: 25515570

Group type: COMPARATOR
Intervention: Normal eyes (control group)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Eyes with retinitis pigmentosa (RP)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups (normal and RP)
Number of subjects: 22
Study: 22101166

Group type: EXPERIMENTAL
Intervention: DNA methylation at GNASAS
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: DNA methylation at INS
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Hypermethylation at one locus
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Hypermethylation at both loci
Number of subjects: 122

Group type: COMPARATOR
Intervention: No association
Number of subjects: 122
Study: 19396540

Group type: EXPERIMENTAL
Intervention: RSA biofeedback
Number of subjects: 38

Group type: COMPARATOR
Intervention: Progressive muscle relaxation (PMR)
Number of subjects: 38
Study: 17897821

Group type: EXPERIMENTAL
Intervention: Goserelin
Number of subjects: 776

Group type: COMPARATOR
Intervention: Control (no further treatment)
Number of subjects: 776
Study: 15295370

Group type: COMPARATOR
Intervention: Foley catheter alone (Foley)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Foley catheter with extra-amniotic saline infusion (EASI)
Number of subjects: 100
Study: 11578668

Group type: EXPERIMENTAL
Intervention: Major Depression Inventory (MDI)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: MDI total score
Number of subjects: 43
Study: 9660036

Group type: EXPERIMENTAL
Intervention: Grapefruit juice
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Orange juice
Number of subjects: 22

Group type: COMPARATOR
Intervention: Mineral water
Number of subjects: 22
Study: 7988297

Group type: COMPARATOR
Intervention: S measurements (in-shoe foot pressure)
Number of subjects: 109

Group type: COMPARATOR
Intervention: H measurements (foot pressure between foot and sock)
Number of subjects: 109

Group type: COMPARATOR
Intervention: B measurements (foot pressure with socks only)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Peak S pressure
Number of subjects: 109

Group type: COMPARATOR
Intervention: Peak H pressure
Number of subjects: 109

Group type: COMPARATOR
Intervention: Peak B pressure
Number of subjects: 109
Study: 3141296

Group type: EXPERIMENTAL
Intervention: Glucose
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fructose
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Xylitol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 24
Study: 29930229

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study: 27017108

Group type: EXPERIMENTAL
Intervention: Water Exchange (WE)
Number of subjects: 704

Group type: COMPARATOR
Intervention: Sedation
Number of subjects: 704
Study: 24978090

Group type: EXPERIMENTAL
Intervention: Structured training program
Number of subjects: 165

Group type: COMPARATOR
Intervention: Unstructured training program
Number of subjects: 165
Study: 22263648

Group type: EXPERIMENTAL
Intervention: Inversion + physiotherapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Physiotherapy alone (control)
Number of subjects: 24